Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1Breast 1

Conditions

Vaping 1Uterine Cervical Dysplasia 1Smoking Cessation 1Cutaneous Squamous Cell Carcinoma 1Breast Neoplasms 1Agnosia 1

Interventions

pembrolizumab 1258Specimen Handling 864Carboplatin 824Magnetic Resonance Spectroscopy 806Cyclophosphamide 798Cisplatin 719Nivolumab 660Paclitaxel 635Gemcitabine 570Radiotherapy 570Biopsy 526Bevacizumab 467Dexamethasone 441fludarabine 403Docetaxel 375venetoclax 369Oxaliplatin 363Capecitabine 355Fluorouracil 354atezolizumab 337Rituximab 333durvalumab 332Doxorubicin 316Pemetrexed 306Radiosurgery 304Drug Therapy 300Ipilimumab 296Standard of Care 288Etoposide 283Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Transdermal Patch × 1 year × Clear all
NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting
48 enrolled
Dermatologic

Cutaneous Squamous Cell Carcinoma

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

University of Oklahoma

Phase NA Completed
31 enrolled
Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting
123 enrolled
Breast

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡